TLPH Insider Trading
Insider Ownership Percentage: 5.70%
Insider Buying (Last 12 Months): $304,347.74
Insider Selling (Last 12 Months): $0.00
Talphera Share Price & Price History
Current Price: $0.81
Price Change: ▲ Price Increase of +0.0222 (2.81%)
As of 04/9/2026 05:00 PM ET
Talphera Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/13/2026 | Vincent J Angotti | CEO | Buy | 213,310 | $0.59 | $125,852.90 | 800,705 | |
| 2/12/2026 | Badri N Dasu | Insider | Buy | 35,000 | $0.81 | $28,350.00 | 76,230 | |
| 2/12/2026 | Raffi Asadorian | CFO | Buy | 45,000 | $0.81 | $36,450.00 | 91,256 | |
| 2/12/2026 | Shakil Aslam | Insider | Buy | 35,000 | $0.81 | $28,350.00 | 83,178 | |
| 2/12/2026 | Vincent J Angotti | CEO | Buy | 105,364 | $0.81 | $85,344.84 | 586,954 | |
| 12/5/2024 | Vincent J Angotti | CEO | Buy | 5,000 | $0.64 | $3,200.00 | 208,066 | |
| 11/27/2024 | Vincent J Angotti | CEO | Buy | 5,000 | $0.73 | $3,650.00 | 203,066 | |
| 6/14/2024 | Vincent J Angotti | CEO | Buy | 1,304 | $1.08 | $1,408.32 | 180,806 | |
| 6/13/2024 | Shakil Aslam | Insider | Buy | 695 | $0.98 | $681.10 | 32,695 | |
| 6/12/2024 | Vincent J Angotti | CEO | Buy | 4,126 | $0.97 | $4,002.22 | 174,932 | |
Talphera Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/17/2026 | Cantor Fitzgerald L. P. | 577,490 | $0.66M | 0.0% | N/A | 1.239% |  |
| 2/17/2026 | Diadema Partners LP | 136,923 | $0.16M | 0.0% | N/A | 0.294% |  |
| 2/17/2026 | Persistent Asset Partners Ltd | 36,630 | $42K | 0.0% | N/A | 0.079% |  |
| 2/16/2026 | Mariner LLC | 58,000 | $66K | 0.0% | +132.0% | 0.124% |  |
| 2/12/2026 | Renaissance Technologies LLC | 257,380 | $0.29M | 0.0% | +412.6% | 0.552% |  |
| 2/12/2026 | Rosalind Advisors Inc. | 3,579,273 | $4.08M | 1.5% | -18.4% | 7.679% |  |
| 2/11/2026 | Empery Asset Management LP | 1,333,497 | $1.52M | 1.3% | N/A | 2.861% |  |
| 2/9/2026 | Geode Capital Management LLC | 342,987 | $0.39M | 0.0% | +107.0% | 0.736% |  |
| 2/2/2026 | AIGH Capital Management LLC | 4,661,502 | $5.31M | 1.3% | +4.6% | 10.001% |  |
| 1/30/2026 | Values First Advisors Inc. | 81,208 | $93K | 0.0% | -17.0% | 0.174% |  |
| 11/17/2025 | Nantahala Capital Management LLC | 3,492,519 | $3.12M | 0.1% | +75.3% | 7.493% |  |
| 11/14/2025 | Virtu Financial LLC | 32,811 | $29K | 0.0% | N/A | 0.070% |  |
| 11/14/2025 | Dauntless Investment Group LLC | 100,000 | $89K | 0.1% | N/A | 0.215% |  |
| 11/13/2025 | Rosalind Advisors Inc. | 4,385,757 | $3.92M | 1.4% | +118.9% | 9.409% |  |
| 11/12/2025 | Group One Trading LLC | 30,415 | $27K | 0.0% | +3,224.0% | 0.065% |  |
| 10/31/2025 | AIGH Capital Management LLC | 4,454,545 | $3.98M | 1.1% | N/A | 9.557% |  |
| 2/14/2025 | Rosalind Advisors Inc. | 613,939 | $0.32M | 0.2% | -19.1% | 3.605% |  |
| 2/11/2025 | Rosalind Advisors Inc. | 613,939 | $0.32M | 0.2% | -19.1% | 3.605% |  |
| 1/29/2025 | Values First Advisors Inc. | 96,553 | $51K | 0.0% | -13.3% | 0.567% |  |
| 10/30/2024 | Rosalind Advisors Inc. | 758,966 | $0.65M | 0.4% | N/A | 4.466% |  |
| 8/20/2024 | Nantahala Capital Management LLC | 1,992,519 | $1.77M | 0.1% | N/A | 11.726% |  |
| 7/31/2024 | Turtle Creek Wealth Advisors LLC | 71,500 | $64K | 0.0% | N/A | 0.421% |  |
Data available starting January 2016
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
Read More on Talphera
Volume
140,645 shs
Average Volume
207,875 shs
Market Capitalization
$40.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.56
Who are the company insiders with the largest holdings of Talphera?